Abstract:Abstract Background Phelan–McDermid syndrome (PMS) or 22q13 deletion syndrome is a rare developmental disorder characterized by hypotonia, developmental delay (DD), intellectual disability (ID), autism spectrum disorder (ASD) and dysmorphic features. Most cases are caused by 22q13 deletions encompassing many genes including SHANK3. Phenotype comparisons between patients with SHANK3 mutations (or deletions only disrupt SHANK3) and 22q13 deletions encompassing more than SHANK3 gene are lacking. Methods A total of 29 Mainland China patients were clinically and genetically evaluated. Data were obtained from medical record review and a standardized medical history questionnaire, and dysmorphology evaluation was conducted via photographic evaluation. We analyzed 22q13 deletions and SHANK3 small mutations and performed genotype–phenotype analysis to determine whether neurological features and other important clinical features are responsible for haploinsufficiency of SHANK3. Results Nineteen patients with 22q13.3 deletions ranging in size from 34 kb to 8.7 Mb, one patient with terminal deletions and duplications, and nine patients with SHANK3 mutations were included. All mutations would cause loss-of function effect and six novel heterozygous variants, c.3838_3839insGG, c.3088delC, c.3526G > T, c.3372dupC, c.3120delC and c.3942delC, were firstly reported. Besides, we demonstrated speech delay (100%), DD/ID (88%), ASD (80%), hypotonia (83%) and hyperactivity (83%) were prominent clinical features. Finally, 100% of cases with monogenic SHANK3 deletion had hypotonia and there was no significant difference between loss of SHANK3 alone and deletions encompassing more than SHANK3 gene in the prevalence of hypotonia, DD/ID, ASD, increased pain tolerance, gait abnormalities, impulsiveness, repetitive behaviors, regression and nonstop crying which were high in loss of SHANK3 alone group. Conclusions This is the first work describing a cohort of Mainland China patients broaden the clinical and molecular spectrum of PMS. Our findings support the effect of 22q13 deletions and SHANK3 point mutations on language impairment and several clinical manifestations, such as DD/ID. We also demonstrated SHANK3 haploinsufficiency was a major contributor to the neurological phenotypes of PMS and also responsible for other important phenotypes such as hypotonia, increased pain tolerance, impulsiveness, repetitive behaviors, regression and nonstop crying.

Clinical and Genomic Evaluation of a Chinese Patient with a Novel Deletion Associated with Phelan-McDermid Syndrome.

Phelan–McDermid Syndrome in Pediatric Patients With Novel Mutations: Genetic and Phenotypic Analyses

Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review

Clinical Features in Patients with Xq23 Microdeletion: A Case Report and Literature Review

[Clinical features and genetic analysis of four children with Phelan-McDermid syndrome]

A 30 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlation and the role of SHANK3 haploinsufficiency in the important phenotypes

A 29 Mainland Chinese Cohort of Patients with Phelan–McDermid Syndrome: Genotype–phenotype Correlations and the Role of SHANK3 Haploinsufficiency in the Important Phenotypes

Phenome-wide profiling identifies genotype-phenotype associations in Phelan-McDermid syndrome using family-sourced data from an international registry

Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations

Characterisation of the clinical phenotype in Phelan-McDermid syndrome

Clinical and genetic study of a child with mental retardation and multiple congenital anomalies and a 16p13.11 microdeletion

[Clinical phenotypes and genetic study of 2 cases with 22q13 deletion syndrome].

The 22q13.3 Deletion Syndrome (Phelan-McDermid Syndrome)

[Clinical and Genetic Analysis of Three Children with 22q13 Deletion Syndrome].

Special clinical entity with 15q26 deletion: a novel case report

Developmental phenotype in Phelan-McDermid (22q13.3 deletion) syndrome: a systematic and prospective study in 34 children

Phenotypic and Genetic Analysis of Four Patients with 13Q33-Q34 Microdeletion

Prenatal Diagnosis of a Fetus with Phelan-McDermid Syndrome

Array CGH-based Detection and Characterization of Combined 1p36 Deletion and 22q13 Duplication in a Boy and a Fetus from a Single Family

Clinical and Genetic Analysis of Three Pediatric Patients with 15q24 Microdeletion Syndrome

Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals